The panellists deliberated on what was required for the 'Creation of a regulatory environment to foster innovation in the Indian biotechnology industry'. Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon minced no words when she vented her frustration saying, "When Indian industry and researchers are raring to go, the Indian regulatory system is holding us back." She recounted how delay in approvals cause Biocon to destroy an investigational product, which is not just a financial loss but also resulted in a loss of time to market and lead time.